One-pot stapling of interchain disulfides of antibodies using an isobutylene motif
Literature Information
Shuang Sun, Padma Akkapeddi, Nuria Martínez-Sáez, Vukosava M. Torres, Carlos Cordeiro, Omar Boutureira
Monoclonal antibodies have emerged as an important class of therapeutics in oncological and autoimmune diseases due to their several attractive properties, such as high binding affinity and specificity. However, it has recently become clear that antibodies recovered from serum show a significantly decreased potency owing to various reasons, including deamidation, oxidation, fragment antigen binding (Fab) exchange, and disulfide shuffling. Fab exchange and disulfide shuffling result because of the instability of disulfides in serum. Herein, we reported a ‘one-pot’ stapling strategy using isobutylene motifs to stabilise the interchain disulfides of antibodies. This general method was applied to a Fab fragment of the anti-HER2 antibody. The stapled Fab was completely stable in the presence of biological thiols. The approach was further applied to two different full-length IgGs, trastuzumab and rituximab, under mild and biocompatible conditions. The binding affinity of the antibody was enhanced, relative to its native form, after being stapled. The stapled structure maintained its effector functions and behaved similarly to its native form in vivo. This work provides a straightforward and scalable method for the stabilisation of antibodies in various formats.
Recommended Journals

Topics in Catalysis

Herald of the Russian Academy of Sciences

Colloid Journal

Journal of Asian Natural Products Research

Main Group Chemistry

Electroanalysis

Polycyclic Aromatic Compounds

Biocatalysis and Biotransformation

Journal of the Indian Institute of Science

Critical Reviews in Solid State and Materials Sciences
Related Literature
Concerning the relative importance of enantiomorphic site vs. chain end control in the stereoselective polymerization of lactides: reactions of (R,R-salen)- and (S,S-salen)–aluminium alkoxides LAlOCH2R complexes (R = CH3 and S-CHMeCl)
Malcolm H. Chisholm, Nathan J. Patmore, Zhiping Zhou
DOI: 10.1039/B413266A
Synthesis of C-arylglycosides via Ru(ii)-catalyzed [2 + 2 + 2] cycloaddition
Yoshihiko Yamamoto, Tomoaki Saigoku, Takashige Ohgai, Hisao Nishiyama, Kenji Itoh
DOI: 10.1039/B411442F
Don't forget Langmuir–Blodgett films
Donald H. McCullough, III, Steven L. Regen
DOI: 10.1039/B410027C
Enzymatic preparation of biotinylated naturally-occurring sialylglycan and its molecular recognition on a quartz-crystal microbalance
Toshiaki Mori, Yoshimi Sekine, Kenji Yamamoto, Yoshio Okahata
DOI: 10.1039/B411082J
Direct intramolecular arylation of unactivated arenes: application to the synthesis of aporphine alkaloids
Marc Lafrance, Nicole Blaquière, Keith Fagnou
DOI: 10.1039/B410394G
Electrical property and water repellency of a networked monolayer film prepared from Au nanoparticles
Hiroshi Shiigi, Yojiro Yamamoto, Hidetaka Yakabe, Shiho Tokonami, Tsutomu Nagaoka
DOI: 10.1039/B212226J
Cyclopropyl fatty acids implicate a radical but not a cation as an intermediate in P450BM3-catalysed hydroxylations
Max J. Cryle, Julia M. U. Stuthe, Paul R. Ortiz de Montellano, James J. De Voss
DOI: 10.1039/B315911F
Dispersing palladium nanoparticles using a water-in-oil microemulsion—homogenization of heterogeneous catalysis
Byunghoon Yoon, Hakwon Kim, Chien M. Wai
DOI: 10.1039/B211836J
The dynamic desorption of krypton from the zeolite chabazite
S. P. Cork, G. Cressey, R. H. Jones, S. J. Teat, V. L. Zholobenko
DOI: 10.1039/B410366C
Stereochemistry of contiguous cyclopropane formation from cascade cyclization of a skipped dienyl homoallyl triflate
Christopher M. Lincoln, James D. White, Alexandre F. T. Yokochi
DOI: 10.1039/B412811G
You might also like
What industries use (1R,3S)-1,3-Cyclopentanediol (CAS: 16326-97-9)?
(1R,3S)-1,3-Cyclopentanediol finds applications in various industries. In the ph...
What precautions should be taken when handling N'-[4-(Dimethylamino)phenyl]-N,N-dimethyl-1,4-benzenediamine (CAS: 637-31-0)?
When handling N'-[4-(Dimethylamino)phenyl]-N,N-dimethyl-1,4-benzenediamine, it i...
Are there alternatives to 5-(2,4-Difluorophenyl)-2-methoxypyrimidine (CAS: 1352318-16-1) in synthesis?
There are several alternatives to 5-(2,4-Difluorophenyl)-2-methoxypyrimidine in ...
What regulatory guidelines apply to 1-(3-Methoxyphenoxy)propan-2-ol (CAS: 382141-68-6)?
1-(3-Methoxyphenoxy)propan-2-ol (CAS: 382141-68-6) must comply with the Globally...
Is Tetrodotoxin Citrate (CAS: 18660-81-6) safe?
Tetrodotoxin Citrate is extremely dangerous and should be handled with extreme c...
What are the main uses of 2-Methyl-2-propanyl [(1R,3S)-3-hydroxycyclopentyl]carbamate (CAS: 225641-84-9)?
2-Methyl-2-propanyl [(1R,3S)-3-hydroxycyclopentyl]carbamate (CAS: 225641-84-9) i...
How should waste containing 4-(2-Hydroxyhexafluoroisopropyl)Benzoic Acid (CAS: 16261-80-6) be handled?
Waste containing 4-(2-Hydroxyhexafluoroisopropyl)Benzoic Acid (CAS: 16261-80-6) ...
How is 2-Methyl-2-proanyl {(2S)-1-[(benzyloxy)amino]-3-hydroxy-3-methyl-1-oxo-2-butanyl}carbamate (CAS: 102507-19-7) typically synthesized?
2-Methyl-2-proanyl {(2S)-1-[(benzyloxy)amino]-3-hydroxy-3-methyl-1-oxo-2-butanyl...
What is Benzeneethanamine, α-ethyl-, hydrochloride (1:1) (CAS: 20735-15-3)?
Benzeneethanamine, α-ethyl-, hydrochloride (1:1) is an organic compound with the...
Are there alternatives to 3-{(E)-[4-(Dimethylamino)phenyl]diazenyl}benzoic acid (CAS: 20691-84-3) in synthesis?
In the synthesis of compounds similar to 3-{(E)-[4-(Dimethylamino)phenyl]diazeny...
Source Journal
Organic & Biomolecular Chemistry

Organic & Biomolecular Chemistry (OBC) publishes original and high impact research and reviews in organic chemistry. We welcome research that shows new or significantly improved protocols or methodologies in total synthesis, synthetic methodology or physical and theoretical organic chemistry as well as research that shows a significant advance in the organic chemistry or molecular design aspects of chemical biology, catalysis, supramolecular and macromolecular chemistry, theoretical chemistry, mechanism-oriented physical organic chemistry, medicinal chemistry or natural products. Articles published in the journal should report new work which makes a highly-significant impact in the field. Routine and incremental work is generally not suitable for publication in the journal. More details about key areas of our scope are below. In all cases authors should include in their article clear rationale for why their research has been carried out.
![N,N'-1,2-Ethanediylbis[2-(vinylsulfonyl)acetamide] structure N,N'-1,2-Ethanediylbis[2-(vinylsulfonyl)acetamide] structure](https://static.chemtradehub.com/structs/667/66710-66-5-b556.webp)
![N-[(1S,2R,4S)-2-Amino-4-(dimethylcarbamoyl)cyclohexyl]-N'-(5-chloro-2-pyridinyl)ethanediamide structure N-[(1S,2R,4S)-2-Amino-4-(dimethylcarbamoyl)cyclohexyl]-N'-(5-chloro-2-pyridinyl)ethanediamide structure](https://static.chemtradehub.com/structs/480/480452-37-7-0898.webp)


